Lixte Biotechnology appoints Jan Schellens as CMO

seekingalpha06-03

LIXTE Biotechnology Holdings(NASDAQ:LIXT) has announced the appointment of Jan Schellens, M.D., Ph.D., as CMO. He assumes the CMO role at LIXTE effective Aug. 1, 2024, succeeding James S. Miser, M.D.,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2440497310?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-03 22:21","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2440497310","market":"sg","top_or_hot":-1,"title":"Lixte Biotechnology appoints Jan Schellens as CMO","media":"seekingalpha","content":"<div>\n<p>LIXTE Biotechnology Holdings(NASDAQ:LIXT) has announced the appointment of Jan Schellens, M.D., Ph.D., as CMO. He assumes the CMO role at LIXTE effective Aug. 1, 2024, succeeding James S. Miser, M.D.,...</p>\n\n<a href=\"https://seekingalpha.com/news/4112349-lixte-biotechnology-appoints-jan-schellens-as-cmo\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lixte Biotechnology appoints Jan Schellens as CMO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLixte Biotechnology appoints Jan Schellens as CMO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-03 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4112349-lixte-biotechnology-appoints-jan-schellens-as-cmo><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>LIXTE Biotechnology Holdings(NASDAQ:LIXT) has announced the appointment of Jan Schellens, M.D., Ph.D., as CMO. He assumes the CMO role at LIXTE effective Aug. 1, 2024, succeeding James S. Miser, M.D.,...</p>\n\n<a href=\"https://seekingalpha.com/news/4112349-lixte-biotechnology-appoints-jan-schellens-as-cmo\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CMO","symbol_name":"卡帕史丹抵押","start_time":0,"source_url":"https://seekingalpha.com/news/4112349-lixte-biotechnology-appoints-jan-schellens-as-cmo","article_id":"2440497310","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2440497310","pubTimestamp":1717424492,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"LIXTE Biotechnology Holdings has announced the appointment of Jan Schellens, M.D., Ph.D., as CMO. He assumes the CMO role at LIXTE effective Aug. 1, 2024, succeeding James S. Miser, M.D., who is leaving the Co. after serving in this capacity since 2020. \"He brings a highly relevant background to LIXTE, and we are fortunate in attracting him to our organization, as we continue to make progress with LB-100 to enhance chemotherapies and immunotherapies and improve outcomes for patients with cancer.\" said Bas van der Baan, LIXTE’s CEO.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CMO":"卡帕史丹抵押","LIXT":"Lixte Biotechnology Holdings Inc.","BK4139":"生物科技"},"translate_title":"Lixte Biotechnology任命Jan Schellens为CMO","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CMO":1,"LIXT":1},"content_text":"LIXTE Biotechnology Holdings(NASDAQ:LIXT) has announced the appointment of Jan Schellens, M.D., Ph.D., as CMO. He assumes the CMO role at LIXTE effective Aug. 1, 2024, succeeding James S. Miser, M.D., who is leaving the Co. after serving in this capacity since 2020. \"He brings a highly relevant background to LIXTE, and we are fortunate in attracting him to our organization, as we continue to make progress with LB-100 to enhance chemotherapies and immunotherapies and improve outcomes for patients with cancer.\" said Bas van der Baan, LIXTE’s CEO.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2440497310"}